30/10/2008
The authors' in silico model (which is the first QSAR study concerning antagonists of CXCR3 in the literature) provides a time- and cost-effective tool for screening existing and virtual libraries of small molecules as well as for designing of novel molecules of desired activity. (Full article available via Pubmed)